Skip to main content

AbbVie aims for new drugs to boost sales as competitors target humira

By The Wall Street Journal  
   February 06, 2023

Company says two newer immune drugs can offset the blockbuster's decline, and it plans to lift a cap on the size of deals it will do.

Full story

Get the latest on healthcare leadership in your inbox.